top of page
Synaptiflora Featured Among Top 10 Leading AI Drug Discovery Companies
https://www.startus-insights.com/innovators-guide/ai-drug-discovery-companies/ We’re excited to share that Synaptiflora has been featured by StartUs Insights in their global overview of AI-driven drug discovery companies . Being recognized alongside innovators shaping the future of pharmaceutical R&D is an important milestone for our team—and a strong validation of the direction we’re building toward. Why This Recognition Matters The StartUs Insights report highlights compa
Fedor Lipskerov
Jan 72 min read
Welcoming Prof. Naama Geva-Zatorsky: Pioneering Microbiome-Immune Insights to Power Synaptiflora’s Mission
We’re proud to welcome Prof. Naama Geva-Zatorsky to Synaptiflora as a scientific advisor. A principal investigator at the Technion –...
Fedor Lipskerov
Apr 8, 20252 min read
The Microbiome-Cancer Connection: A New Frontier in Diagnosis and Treatment
In recent years, researchers have discovered a profound link between the human microbiome and cancer, sparking potential breakthroughs in...
Fedor Lipskerov
Oct 29, 20243 min read
Empowering Pharmaceutical Innovation through AI and Microbiome
The pharmaceutical industry is entering a transformative era, driven by the convergence of two of the most exciting frontiers of science:...
Fedor Lipskerov
Oct 9, 20244 min read
bottom of page